Clindamycin vs Durvalumab

## Clindamycin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Clindamycin** and **Durvalumab**.

## Mechanism of Action

**Clindamycin**: Binds 50S ribosomal subunit inhibiting protein synthesis.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Clindamycin — 2-3 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Clindamycin — C18H33ClN2O5S; Durvalumab — N/A.

**Molecular Weight**: Clindamycin — 424.9830 g/mol; Durvalumab — N/A.

**Type**: Clindamycin — Small molecule; Durvalumab — Antibody.